The Innovation Blueprint
30 years in pharma and one approved drug says everything. Randall B. Riggs breaks down why cancer resists even the best science, how mutation outpaces static treatments, and why resilience matters more than breakthroughs. Progress is real, but the odds, funding gaps, and biology keep the fight brutally uneven.
39 episodes
Comments
0Be the first to comment
Sign up now and become a member of the The Innovation Blueprint community!